1995
DOI: 10.3109/17453679508995504
|View full text |Cite
|
Sign up to set email alerts
|

Antivitamin K prevents heterotopic ossification after hip arthroplasty in diffuse idiopathic skeletal hyperostosis: A retrospective study in 67 patients

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
4
0

Year Published

2000
2000
2024
2024

Publication Types

Select...
6
4

Relationship

0
10

Authors

Journals

citations
Cited by 27 publications
(5 citation statements)
references
References 18 publications
(19 reference statements)
1
4
0
Order By: Relevance
“…These patients, however, may be at a higher risk of heterotopic ossification postoperatively. 1,24 The current investigation confirmed that hip arthroscopic preservation surgery hip is of great promise for individuals with extraspinal DISH of the hip joint.…”
Section: Discussionsupporting
confidence: 73%
“…These patients, however, may be at a higher risk of heterotopic ossification postoperatively. 1,24 The current investigation confirmed that hip arthroscopic preservation surgery hip is of great promise for individuals with extraspinal DISH of the hip joint.…”
Section: Discussionsupporting
confidence: 73%
“…67 Due to the propensity of patients with DISH to develop heterotopic ossification following joint replacement surgeries, it has been suggested to adopt preventive measures such as the use of NSAIDs and/or irradiation in the perioperative period. [68][69][70] However, the prevention or inhibition of soft tissue ossification has not been investigated systematically in patients with DISH. Therapeutic studies in DISH are hampered by several reasons.…”
Section: Therapeutic Considerationsmentioning
confidence: 99%
“…There is substantial case-control evidence that combined nonsteroidal antiinflammatory medications and local radiation therapy may have an additive or synergistic beneficial effect in the prevention of recurrence as compared with the effect of monotherapy with either modality alone [53][54][55][56] . Numerous other agents, including the early bisphosphonate etidronate, have been studied in human and animal trials of heterotopic ossification prevention, with varying levels of success and supporting evidence [57][58][59][60][61][62][63][64][65][66] .…”
Section: Primary and Secondary Prophylaxis Against Heterotopic Ossifimentioning
confidence: 99%